Index -
P/E -
EPS (ttm) -3.72
Insider Own 35.85%
Shs Outstand 5.92M
Perf Week 4.02%
Market Cap 40.12M
Forward P/E -
EPS next Y -2.73
Insider Trans -0.45%
Shs Float 3.82M
Perf Month 9.08%
Income -15.64M
PEG -
EPS next Q -0.81
Inst Own 35.18%
Short Float 13.67%
Perf Quarter -16.71%
Sales 199.73M
P/S 0.20
EPS this Y 86.33%
Inst Trans 21.07%
Short Ratio 8.64
Perf Half Y -52.81%
Book/sh -9.30
P/B -
EPS next Y -75.21%
ROA -13.76%
Short Interest 0.52M
Perf Year -57.94%
Cash/sh 2.35
P/C 2.87
EPS next 5Y 35.37%
ROE -
52W Range 5.01 - 18.70
Perf YTD -49.44%
Dividend Est. -
P/FCF -
EPS past 5Y -15.00%
ROI -141.95%
52W High -64.02%
Beta 0.14
Dividend TTM -
Quick Ratio 0.57
Sales past 5Y 306.01%
Gross Margin 80.24%
52W Low 34.47%
ATR (14) 0.69
Dividend Ex-Date -
Current Ratio 0.57
EPS Y/Y TTM 89.94%
Oper. Margin -1.61%
RSI (14) 47.58
Volatility 8.92% 9.26%
Employees 153
Debt/Eq -
Sales Y/Y TTM 475.53%
Profit Margin -7.83%
Recom 1.00
Target Price 15.33
Option/Short No / Yes
LT Debt/Eq -
EPS Q/Q 162.04%
Payout -
Rel Volume 2.19
Prev Close 6.84
Sales Surprise 1631.17%
EPS Surprise 276.77%
Sales Q/Q 258.77%
Earnings May 15 BMO
Avg Volume 60.44K
Price 6.73
SMA20 -6.96%
SMA50 0.56%
SMA200 -23.42%
Trades
Volume 132,351
Change -1.61%
Date
Action
Analyst
Rating Change
Price Target Change
Nov-09-23 Downgrade
Mizuho
Buy → Neutral
$31 → $1
Nov-09-23 Downgrade
H.C. Wainwright
Buy → Neutral
Nov-09-23 Downgrade
Evercore ISI
Outperform → In-line
Jul-20-22 Downgrade
Citigroup
Neutral → Sell
$8 → $3
Jul-13-22 Downgrade
Stifel
Buy → Hold
$16 → $5
Jul-13-22 Downgrade
JP Morgan
Overweight → Neutral
$10
May-10-22 Downgrade
Citigroup
Buy → Neutral
$15 → $8
May-13-21 Upgrade
JP Morgan
Neutral → Overweight
$23 → $29
Dec-09-20 Downgrade
Citigroup
Buy → Neutral
$20 → $27
Dec-08-20 Reiterated
H.C. Wainwright
Buy
$28 → $31
Nov-10-20 Reiterated
H.C. Wainwright
Buy
$26 → $28
Jun-30-20 Initiated
Evercore ISI
Outperform
Jun-15-20 Initiated
H.C. Wainwright
Buy
$25
Apr-23-20 Upgrade
Citigroup
Neutral → Buy
$14
Nov-08-19 Downgrade
JP Morgan
Overweight → Neutral
$43 → $22
Sep-27-19 Downgrade
Goldman
Neutral → Sell
$14 → $9
Sep-16-19 Downgrade
Jefferies
Buy → Hold
$32 → $15
Jun-04-19 Upgrade
Citigroup
Sell → Neutral
$23 → $24
May-30-19 Initiated
ROTH Capital
Buy
May-23-19 Initiated
Stifel
Buy
Show Previous Ratings
May-16-25 08:50PM
May-15-25 08:58AM
(Associated Press Finance) +15.13%
08:35AM
08:30AM
May-14-25 08:25AM
09:10AM
Loading…
May-13-25 09:10AM
May-05-25 05:06PM
(Business Wire) -7.29%
+5.79%
Apr-10-25 08:52AM
Mar-13-25 12:00PM
Mar-07-25 05:10PM
04:16PM
(Associated Press Finance)
04:01PM
Feb-14-25 09:55AM
08:11AM
Feb-07-25 04:01PM
05:00AM
Loading…
Jan-22-25 05:00AM
Jan-21-25 01:11PM
07:30AM
Jan-17-25 07:00AM
Jan-16-25 12:28PM
08:30AM
Jan-02-25 12:00PM
Dec-04-24 07:00AM
Dec-03-24 07:00AM
Nov-27-24 04:01PM
Nov-13-24 04:01PM
(Business Wire) +22.19%
-10.45%
Nov-12-24 05:15PM
04:13PM
(Associated Press Finance)
04:01PM
Nov-05-24 04:01PM
12:00PM
Loading…
Oct-15-24 12:00PM
Oct-04-24 04:01PM
Sep-30-24 03:16AM
Sep-13-24 07:02PM
(GuruFocus.com) +20.30%
-11.52%
Sep-06-24 04:01PM
(Business Wire) -5.30%
-5.28%
Sep-04-24 04:01PM
(Business Wire) +32.89%
+10.50%
Sep-03-24 04:16PM
Aug-12-24 06:10PM
05:07PM
(Associated Press Finance)
05:00PM
Aug-07-24 04:01PM
Jul-19-24 06:12AM
(Pharmaceutical Technology)
Jul-17-24 04:13PM
(Pharmaceutical Technology)
-12.82%
09:00AM
07:00AM
Jul-16-24 07:00AM
Jul-15-24 12:00PM
Jul-05-24 04:01PM
Jul-03-24 07:57PM
Jun-21-24 04:01PM
Jun-17-24 08:00AM
Jun-12-24 07:00AM
Jun-11-24 07:00AM
Jun-07-24 04:01PM
Jun-05-24 04:01PM
May-29-24 04:01PM
May-20-24 11:57AM
09:25AM
May-09-24 10:57PM
05:15PM
04:17PM
(Associated Press Finance)
04:01PM
May-03-24 04:01PM
Apr-05-24 04:01PM
Mar-28-24 01:53PM
09:40AM
08:40AM
(Associated Press Finance)
08:30AM
Feb-29-24 09:05AM
Feb-28-24 04:30PM
Feb-14-24 09:00AM
Jan-31-24 06:30PM
Jan-11-24 01:26AM
01:26AM
Jan-08-24 09:00AM
08:00AM
Jan-04-24 04:01PM
Dec-20-23 04:01PM
Dec-11-23 12:00PM
Dec-01-23 04:01PM
Nov-29-23 06:05PM
Nov-24-23 12:29PM
Nov-22-23 04:01PM
09:14AM
Nov-10-23 04:01PM
Nov-09-23 08:23AM
06:40AM
Nov-08-23 05:35PM
Nov-05-23 12:50PM
Nov-02-23 05:42AM
02:25AM
(Thomson Reuters StreetEvents)
Nov-01-23 08:35AM
(Associated Press Finance)
08:30AM
Oct-06-23 04:01PM
Sep-21-23 09:19AM
Sep-19-23 04:01PM
Sep-01-23 04:01PM
Aug-31-23 04:01PM
Aug-13-23 10:44AM
Aug-08-23 05:30PM
Atara Biotherapeutics, Inc. is an allogeneic T-cell immunotherapy company, which engages in the development of transformative therapies for patients with serious diseases including solid tumors, hematologic cancers, and autoimmune diseases. It also delivers off-the-shelf treatments to patients with high unmet medical need. Its product pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in Thousand Oaks, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Nguyen AnhCo Director May 16 '25 Proposed Sale 7.61 3,471 26,414 May 16 07:32 PM Grant-Huerta Yanina Officer May 16 '25 Proposed Sale 7.61 2,350 17,884 May 16 07:27 PM Nguyen AnhCo President and CEO Mar 03 '25 Sale 7.00 3,331 23,307 74,123 Mar 05 05:17 PM Hyllengren Eric J EVP, CFO and COO Mar 03 '25 Sale 7.00 1,211 8,473 56,231 Mar 05 05:17 PM Henrich Jill EVP, Chief Regulatory Officer Mar 03 '25 Sale 7.00 1,059 7,410 18,679 Mar 05 05:16 PM Nguyen AnhCo Officer Mar 03 '25 Proposed Sale 6.91 3,929 27,149 Mar 03 06:30 PM Hyllengren Eric J Officer Mar 03 '25 Proposed Sale 6.91 1,426 9,854 Mar 03 06:29 PM Henrich Jill Officer Mar 03 '25 Proposed Sale 6.91 1,245 8,603 Mar 03 06:27 PM Henrich Jill EVP, Chief Regulatory Officer Nov 18 '24 Sale 11.20 1,000 11,198 19,378 Nov 20 06:05 PM Hyllengren Eric J EVP, CFO and COO Nov 18 '24 Sale 11.20 1,364 15,274 23,392 Nov 20 06:04 PM Nguyen AnhCo President and CEO Nov 18 '24 Sale 11.20 1,664 18,633 77,454 Nov 20 06:04 PM Nguyen AnhCo Officer Nov 18 '24 Proposed Sale 12.00 1,857 22,284 Nov 18 05:58 PM Murugan Amar Former Officer Nov 18 '24 Proposed Sale 12.00 1,342 16,104 Nov 18 05:56 PM Hyllengren Eric J Officer Nov 18 '24 Proposed Sale 12.00 1,517 18,204 Nov 18 05:55 PM Henrich Jill Officer Nov 18 '24 Proposed Sale 12.00 1,112 13,344 Nov 18 05:54 PM Touchon Pascal President and CEO Aug 16 '24 Sale 6.63 3,038 20,139 70,127 Aug 20 06:27 PM Nguyen AnhCo EVP, Chief Sci. & Tech Officer Aug 16 '24 Sale 6.63 1,821 12,072 34,118 Aug 20 06:27 PM Murugan Amar EVP, Chief Legal Officer Aug 16 '24 Sale 6.63 1,158 7,677 26,827 Aug 20 06:27 PM Hyllengren Eric J EVP, CFO Aug 16 '24 Sale 6.63 1,070 7,093 24,756 Aug 20 06:27 PM Henrich Jill EVP, Global Head RA & Quality Aug 16 '24 Sale 6.63 963 6,384 20,378 Aug 20 06:26 PM Touchon Pascal Director Aug 16 '24 Proposed Sale 8.02 3,525 28,270 Aug 16 04:12 PM Nguyen AnhCo Officer Aug 16 '24 Proposed Sale 8.02 2,114 16,954 Aug 16 04:10 PM Murugan Amar Officer Aug 16 '24 Proposed Sale 8.02 1,342 10,763 Aug 16 04:09 PM Hyllengren Eric J Officer Aug 16 '24 Proposed Sale 8.02 1,239 9,937 Aug 16 04:08 PM Henrich Jill Officer Aug 16 '24 Proposed Sale 8.02 1,113 8,926 Aug 16 04:06 PM